News

Volumetric modulated arc therapy (VMAT) is a new advanced form of intensity modulated radiation therapy (IMRT) where the treatment machine rotates around the patient while the treatment beam

On May 18, 2007, Taro and Sun Pharma’s subsidiaries entered into a merger agreement whereby Sun Pharma’s subsidiary would acquire Taro, which the Taro board of directors unanimously

Mr Cordani joined Cigna in 1991 and prior to his appointment as president of Cigna HealthCare, served as president of health segments for Cigna HealthCare and as senior

As planned, the three randomized, placebo-controlled, double-masked studies together enrolled a total of about 560 patients at 58 sites in seven countries. In the Luminate program Luveniq is

For the next five years, 85% of PinnacleHealth’s newly acquired medical imaging systems will come from Toshiba’s full product portfolio including CT, Interventional Labs, X-ray, Ultrasound and MRI.

Dr Dougherty has a doctorate in molecular and cellular pharmacology from the University of Miami Miller School of Medicine. Boris Reznik, chairman of OncoMune, said: “Dr Dougherty has

The Phase II, multi-center, international randomized, double-blind, placebo-controlled study (Mpex 204) is expected to enroll 140 stable cystic fibrosis (CF) patients to evaluate the safety, tolerability and efficacy

Ranbaxy believes that it has first-to-file status on Valganciclovir tablets, thereby providing a potential of 180-days of marketing exclusivity, offering a significant opportunity in the future. Valganciclovir HCl

These rights enable Pharming to accelerate pharmaceutical development of recombinant human fibrinogen (rhFIB) and stimulate medical device development through its biomaterials program. Pharming has obtained exclusive licenses on